# XBP Global Holdings, Inc.: financial statements, quarterly

XBP · Nasdaq · CIK 1839530 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xbp.md) · [Financials](/companies/xbp/financials.md) · [Filings](/companies/xbp/filings.md) · [Insiders](/companies/xbp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xbp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [233](/filings/0001104659-25-112648.md) | [209 d](/filings/0001104659-26-037421.md) | [192](/filings/0001104659-26-062511.md) | [183](/filings/0001104659-26-097350.md) | [197](/filings/0001104659-26-062511.md) | [191](/filings/0001104659-26-097350.md) |
| Gross profit | $m | [9.5](/filings/0001558370-24-007866.md) | [11.7](/filings/0001558370-24-011812.md) | [9.3](/filings/0001558370-24-015341.md) | [9.1 d](/filings/0001558370-25-003247.md) | [10.0](/filings/0001558370-25-007882.md) | [6.6](/filings/0001558370-25-011484.md) | [44.0](/filings/0001104659-25-112648.md) | [45.1 d](/filings/0001104659-26-037421.md) | [41.3](/filings/0001104659-26-062511.md) | [37.7](/filings/0001104659-26-097350.md) | [45.2](/filings/0001104659-26-062511.md) | [41.2](/filings/0001104659-26-097350.md) |
| Operating income | $m | [(1.0)](/filings/0001558370-24-007866.md) | [1.4](/filings/0001558370-24-011812.md) | [0.3](/filings/0001558370-24-015341.md) | [(2.4) d](/filings/0001558370-25-003247.md) | [1.3](/filings/0001558370-25-007882.md) | [(1.4)](/filings/0001558370-25-011484.md) | [2.1](/filings/0001104659-25-112648.md) | [(107) d](/filings/0001104659-26-037421.md) | [6.0](/filings/0001104659-26-062511.md) | [5.6](/filings/0001104659-26-097350.md) | [(15.1)](/filings/0001104659-26-062511.md) | [(3.7)](/filings/0001104659-26-097350.md) |
| Interest expense | $m | not reported | [0.0](/filings/0001213900-23-067004.md) | [0.2](/filings/0001213900-23-086215.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001558370-24-007866.md) | [0.4](/filings/0001558370-24-011812.md) | [1.0](/filings/0001558370-24-015341.md) | [(0.9) d](/filings/0001558370-25-003247.md) | [0.5](/filings/0001558370-25-007882.md) | [0.5](/filings/0001558370-25-011484.md) | [4.4](/filings/0001104659-25-112648.md) | [0.6 d](/filings/0001104659-26-037421.md) | [2.0](/filings/0001104659-26-062511.md) | [0.5](/filings/0001104659-26-097350.md) | [(1.4)](/filings/0001104659-26-062511.md) | [(1.8)](/filings/0001104659-26-097350.md) |
| Net income | $m | [(2.5)](/filings/0001558370-24-015341.md) | [(0.6)](/filings/0001558370-24-015341.md) | [(2.9)](/filings/0001558370-24-015341.md) | [(5.1) d](/filings/0001558370-25-003247.md) | [(25.7)](/filings/0001104659-25-112648.md) | [(28.8)](/filings/0001104659-25-112648.md) | [(28.3)](/filings/0001104659-25-112648.md) | [(132) d](/filings/0001104659-26-037421.md) | [39.6](/filings/0001104659-26-097350.md) | [(65.1)](/filings/0001104659-26-097350.md) | [(26.8)](/filings/0001104659-26-097350.md) | [(16.7)](/filings/0001104659-26-097350.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001558370-24-007866.md) | [(0.03)](/filings/0001558370-24-011812.md) | [(0.13)](/filings/0001558370-24-015341.md) | not reported | [(0.07)](/filings/0001558370-25-007882.md) | [(0.16)](/filings/0001558370-25-011484.md) | [(0.09)](/filings/0001558370-24-015341.md) | not reported | [(0.14)](/filings/0001558370-25-007882.md) | [(0.19)](/filings/0001558370-25-011484.md) | [(2.28)](/filings/0001104659-26-062511.md) | [(1.42)](/filings/0001104659-26-097350.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001558370-24-007866.md) | [(0.03)](/filings/0001558370-24-011812.md) | [(0.13)](/filings/0001558370-24-015341.md) | not reported | [(0.07)](/filings/0001558370-25-007882.md) | [(0.16)](/filings/0001558370-25-011484.md) | [(0.09)](/filings/0001558370-24-015341.md) | not reported | [(0.14)](/filings/0001558370-25-007882.md) | [(0.19)](/filings/0001558370-25-011484.md) | [(2.28)](/filings/0001104659-26-062511.md) | [(1.42)](/filings/0001104659-26-097350.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.5](/filings/0001558370-25-003247.md) | [3.5](/filings/0001558370-24-007866.md) | [15.6](/filings/0001558370-24-011812.md) | [7.8](/filings/0001558370-24-015341.md) | [11.6](/filings/0001104659-26-037421.md) | [9.7](/filings/0001558370-25-007882.md) | [6.1](/filings/0001558370-25-011484.md) | [11.7](/filings/0001104659-26-037421.md) | [34.5](/filings/0001104659-25-112648.md) | [37.1](/filings/0001104659-26-097350.md) | [28.5](/filings/0001104659-26-062511.md) | [18.6](/filings/0001104659-26-097350.md) |
| Current assets | $m | [49.9](/filings/0001558370-25-003247.md) | [47.7](/filings/0001558370-24-007866.md) | [57.7](/filings/0001558370-24-011812.md) | [47.5](/filings/0001558370-24-015341.md) | [124](/filings/0001104659-26-037421.md) | [47.5](/filings/0001558370-25-007882.md) | [50.6](/filings/0001558370-25-011484.md) | [192](/filings/0001104659-26-037421.md) | [242](/filings/0001104659-25-112648.md) | [240](/filings/0001104659-26-097350.md) | [222](/filings/0001104659-26-062511.md) | [197](/filings/0001104659-26-097350.md) |
| Total assets | $m | [103](/filings/0001558370-25-003247.md) | [99.1](/filings/0001558370-24-007866.md) | [108](/filings/0001558370-24-011812.md) | [99.6](/filings/0001558370-24-015341.md) | [390](/filings/0001104659-26-037421.md) | [99.0](/filings/0001558370-25-007882.md) | [105](/filings/0001558370-25-011484.md) | [1,088](/filings/0001104659-26-037421.md) | [948](/filings/0001104659-25-112648.md) | [902](/filings/0001104659-26-097350.md) | [871](/filings/0001104659-26-062511.md) | [828](/filings/0001104659-26-097350.md) |
| Current liabilities | $m | [82.1](/filings/0001558370-25-003247.md) | [80.8](/filings/0001558370-24-007866.md) | [79.9](/filings/0001558370-24-011812.md) | [74.5](/filings/0001558370-24-015341.md) | [1,790](/filings/0001104659-26-037421.md) | [77.8](/filings/0001558370-25-007882.md) | [89.1](/filings/0001558370-25-011484.md) | [248](/filings/0001104659-26-037421.md) | [330](/filings/0001104659-25-112648.md) | [322](/filings/0001104659-26-097350.md) | [331](/filings/0001104659-26-062511.md) | [308](/filings/0001104659-26-097350.md) |
| Total liabilities | $m | [115](/filings/0001558370-25-003247.md) | [113](/filings/0001558370-24-007866.md) | [126](/filings/0001558370-24-011812.md) | [120](/filings/0001558370-24-015341.md) | [1,847](/filings/0001104659-26-037421.md) | [119](/filings/0001558370-25-007882.md) | [133](/filings/0001558370-25-011484.md) | [681](/filings/0001104659-26-037421.md) | [817](/filings/0001104659-25-112648.md) | [815](/filings/0001104659-26-097350.md) | [809](/filings/0001104659-26-062511.md) | [781](/filings/0001104659-26-097350.md) |
| Long-term debt | $m | [12.8](/filings/0001558370-25-003247.md) | [12.6](/filings/0001558370-24-007866.md) | [26.8](/filings/0001558370-24-011812.md) | [26.4](/filings/0001558370-24-015341.md) | [1.5](/filings/0001104659-26-037421.md) | [24.3](/filings/0001558370-25-007882.md) | [25.6](/filings/0001558370-25-011484.md) | [307](/filings/0001104659-26-037421.md) | [347](/filings/0001104659-25-112648.md) | [353](/filings/0001104659-26-097350.md) | [349](/filings/0001104659-26-062511.md) | [348](/filings/0001104659-26-097350.md) |
| Current portion of debt | $m | [3.9](/filings/0001558370-25-003247.md) | [4.7](/filings/0001558370-24-007866.md) | [5.4](/filings/0001558370-24-011812.md) | [5.0](/filings/0001558370-24-015341.md) | [1,433](/filings/0001104659-26-037421.md) | [5.4](/filings/0001558370-25-007882.md) | [6.8](/filings/0001558370-25-011484.md) | not reported | [34.9](/filings/0001104659-25-112648.md) | [34.3](/filings/0001104659-26-097350.md) | [32.3](/filings/0001104659-26-062511.md) | [25.3](/filings/0001104659-26-097350.md) |
| Shareholders' equity | $m | [(1,244)](/filings/0001104659-26-037421.md) | [(1,260)](/filings/0001104659-25-112648.md) | [(1,291)](/filings/0001104659-25-112648.md) | [(1,325)](/filings/0001104659-25-112648.md) | [(1,457)](/filings/0001104659-26-097350.md) | [(1,418)](/filings/0001104659-26-097350.md) | [(1,487)](/filings/0001104659-26-097350.md) | [437](/filings/0001104659-26-037421.md) | [131](/filings/0001104659-25-112648.md) | [87.3](/filings/0001104659-26-097350.md) | [62.6](/filings/0001104659-26-097350.md) | [46.5](/filings/0001104659-26-097350.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.7)](/filings/0001558370-24-007866.md) | [3.3 d](/filings/0001558370-24-011812.md) | [3.2 d](/filings/0001558370-24-015341.md) | [(3.3) d](/filings/0001558370-25-003247.md) | [(3.6)](/filings/0001558370-25-007882.md) | [(1.9) d](/filings/0001558370-25-011484.md) | [(1.5) d](/filings/0001104659-25-112648.md) | [30.3 d](/filings/0001104659-26-037421.md) | [(43.7)](/filings/0001104659-26-062511.md) | [(32.1) d](/filings/0001104659-26-097350.md) | [(5.0)](/filings/0001104659-26-062511.md) | [(10.1) d](/filings/0001104659-26-097350.md) |
| Capital expenditure | $m | [0.6](/filings/0001558370-24-007866.md) | [1.4 d](/filings/0001558370-24-011812.md) | [0.3 d](/filings/0001558370-24-015341.md) | [0.1 d](/filings/0001558370-25-003247.md) | [0.4](/filings/0001558370-25-007882.md) | [0.2 d](/filings/0001558370-25-011484.md) | [4.6 d](/filings/0001104659-25-112648.md) | [1.1 d](/filings/0001104659-26-037421.md) | [1.3](/filings/0001104659-26-062511.md) | [1.0 d](/filings/0001104659-26-097350.md) | [1.1](/filings/0001104659-26-062511.md) | [1.3 d](/filings/0001104659-26-097350.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.8](/filings/0001558370-24-007866.md) | [21.8](/filings/0001558370-24-011812.md) | [21.8](/filings/0001558370-24-015341.md) | [30.2](/filings/0001558370-25-007882.md) | [30.2](/filings/0001558370-25-011484.md) | [30.2](/filings/0001558370-24-015341.md) | [30.9](/filings/0001558370-25-007882.md) | [35.9](/filings/0001558370-25-011484.md) | [11.8](/filings/0001104659-26-062511.md) | [11.8](/filings/0001104659-26-097350.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,881,339 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097350.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.